This Article
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Grimes, J. D.
Right arrow Articles by Preston, D. N.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Grimes, J. D.
Right arrow Articles by Preston, D. N.

Canadian Medical Association Journal, Vol 126, Issue 1 23-25, Copyright © 1982 by Canadian Medical Association

JOURNAL ARTICLE

Adverse neurologic effects of metoclopramide

J. D. Grimes, M. N. Hassan and D. N. Preston

Metoclopramide hydrochloride is now commonly prescribed for a variety of gastrointestinal disorders. Over a 2-year period 18 patients with neurologic disorders induced by metoclopramide were assessed at the Parkinson's disease clinic of the Ottawa Civic Hospital. During metoclopramide therapy acute transient dystonic reactions were seen in 4 patients, and parkinsonism, which was frequently misdiagnosed and treated as classic Parkinson's disease, was seen in 12 patients. After treatment with metoclopramide was stopped, tardive dyskinesia appeared in seven patients and has persisted for up to 15 months in three patients. Parkinsonism and tardive dyskinesia occurred in older patients undergoing long-term therapy with metoclopramide. This experience, therefore, suggests that such treatment, especially in older patients, should be avoided.


This article has been cited by other articles:


Home page
 Hum Exp ToxicolHome page
A. Tracqui, C. Mutter-Schmidt, P. Kintz, C. Berton, and P. Mangin
Amisulpride poisoning: a report on two cases
Human and Experimental Toxicology, March 1, 1995; 14(3): 294 - 298.
[Abstract] [PDF]

Home page
 Arch Intern MedHome page
L. Ganzini, D. E. Casey, W. F. Hoffman, and A. L. McCall
The Prevalence of Metoclopramide-Induced Tardive Dyskinesia and Acute Extrapyramidal Movement Disorders
Arch Intern Med, June 28, 1993; 153(12): 1469 - 1475.
[Abstract] [PDF]

Home page
 Arch Fam MedHome page
D. D. Sewell and D. V. Jeste
Metoclopramide-Associated Tardive Dyskinesia: An Analysis of 67 Cases
Arch Fam Med, November 1, 1992; 1(2): 271 - 278.
[Abstract] [PDF]

Home page
 Arch Intern MedHome page
L. G. Miller and J. Jankovic
Metoclopramide-Induced Movement Disorders: Clinical Findings With a Review of the Literature
Arch Intern Med, November 1, 1989; 149(11): 2486 - 2492.
[Abstract] [PDF]

Home page
 Arch Intern MedHome page
D. A. Lieberman
Medical Therapy for Chronic Reflux Esophagitis: Long-term Follow-up
Arch Intern Med, October 1, 1987; 147(10): 1717 - 1720.
[Abstract] [PDF]

Home page
 Arch Intern MedHome page
L. S. Friedman, L. A. Weinrauch, and J. A. D'Elia
Metoclopramide-Induced Neuroleptic Malignant Syndrome
Arch Intern Med, August 1, 1987; 147(8): 1495 - 1497.
[Abstract] [PDF]

Home page
 ANN INTERN MEDHome page
D. A. LIEBERMAN and E. B. KEEFFE
Treatment of Severe Reflux Esophagitis with Cimetidine and Metoclopramide
Ann Intern Med, January 1, 1986; 104(1): 21 - 26.
[Abstract] [PDF]

Home page
 Arch NeurolHome page
J. D. Grimes and P. O. Magner
Safety of Domperidone in Metoclopramide-Induced Parkinsonism
Arch Neurol, April 1, 1984; 41(4): 363 - 364.
[Abstract] [PDF]

Home page
 Arch NeurolHome page
D. Buchholz and S. Kariya
Metoclopramide-Induced Parkinsonism
Arch Neurol, August 1, 1983; 40(8): 528 - 529.
[Abstract] [PDF]

Home page
 ANN INTERN MEDHome page
D. E. CASEY
Metoclopramide Side Effects
Ann Intern Med, May 1, 1983; 98(5_Part_1): 673 - 674.
[Abstract] [PDF]